Cited by 72Radiomics and Machine Learning in Medical ImagingPancreatic and Hepatic Oncology ResearchAI in cancer detection

Radiomic features at CT can distinguish pancreatic cancer from noncancerous pancreas

Open access
Chen, Po-Ting, Chang, Dawei, Yen, Huihsuan, Liu, Kao-Lang, Huang, Su-Yun, Roth, Holger, Wu, Ming-Shiang, Liao, Wei-Chih +1 more·2021·Radiology: Imaging Cancer

Abstract

Purpose To identify distinguishing CT radiomic features of pancreatic ductal adenocarcinoma (PDAC) and to investigate whether radiomic analysis with machine learning can distinguish between patients who have PDAC and those who do not. Materials and Methods This retrospective study included contrast material–enhanced CT images in 436 patients with PDAC and 479 healthy controls from 2012 to 2018 from Taiwan that were randomly divided for training and testing. Another 100 patients with PDAC (enriched for small PDACs) and 100 controls from Taiwan were identified for testing (from 2004 to 2011). An additional 182 patients with PDAC and 82 healthy controls from the United States were randomly divided for training and testing. Images were processed into patches. An XGBoost (https://xgboost.ai/) model was trained to classify patches as cancerous or noncancerous. Patients were classified as either having or not having PDAC on the basis of the proportion of patches classified as cancerous. For both patch-based and patient-based classification, the models were characterized as either a local model (trained on Taiwanese data only) or a generalized model (trained on both Taiwanese and U.S. data). Sensitivity, specificity, and accuracy were calculated for patch- and patient-based analysis for the models. Results The median tumor size was 2.8 cm (interquartile range, 2.0–4.0 cm) in the 536 Taiwanese patients with PDAC (mean age, 65 years ± 12 [standard deviation]; 289 men). Compared with normal pancreas, PDACs had lower values for radiomic features reflecting intensity and higher values for radiomic features reflecting heterogeneity. The performance metrics for the developed generalized model when tested on the Taiwanese and U.S. test data sets, respectively, were as follows: sensitivity, 94.7% (177 of 187) and 80.6% (29 of 36); specificity, 95.4% (187 of 196) and 100% (16 of 16); accuracy, 95.0% (364 of 383) and 86.5% (45 of 52); and area under the curve, 0.98 and 0.91. Conclusion Radiomic analysis with machine learning enabled accurate detection of PDAC at CT and could identify patients with PDAC. Keywords: CT, Computer Aided Diagnosis (CAD), Pancreas, Computer Applications-Detection/Diagnosis Supplemental material is available for this article. © RSNA, 2021 An earlier incorrect version of this article appeared online. This article was corrected on July 30, 2021.

Integrity signals

Registry

Crossref · 10.1148/rycan.2021210010

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 24 · Cited by 72

Authors
Chen, P.-T., Chang, D., Yen, H., Liu, K.-L., Huang, S.-Y., Roth, H., Wu, M.-S., Liao, W.-C., & Wang, W.
Affiliations
National Taiwan University (TW)
Venue
Radiology: Imaging Cancer
Published
2021-07-01
Volume
3
Issue
4
Pages
e210010
ISSN
2638-616X (ISSN-L)
OpenAlex
W3177681144
Cited by
72
References
24
Citations by year
2026: 11 · 2025: 23 · 2024: 11 · 2023: 19 · 2022: 7 · 2021: 1
FWCI
5.02
Type
journal article
Language
en
Open access
Locations
  • Radiology Imaging Cancer (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Science and Technology, Taiwan (MOST 107-2634-F-002-014-, MOST 107-2634-F-002-016-, MOST 108-2634-F-002-011-, MOST 108-2634-F-002-013-, MOST 109-2634-F-002-028-, MOST 110-2634-F-002-030-)
  • National Center for Theoretical Sciences Mathematics Division
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
pancreatic ductal adenocarcinoma, radiomic features, computed tomography, computer-aided detection, XGBoost, patch-based classification, cross-validation, small pancreatic tumors, tumor heterogeneity, intensity features, United States, model generalization, contrast-enhanced CT, image patches, machine learning classification, radiomics, pancreatic cancer diagnosis
MeSH terms
Aged, Humans, Male, Pancreas, Pancreatic Neoplasms, Retrospective Studies, Tomography, X-Ray Computed, Carcinoma, Pancreatic Ductal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review